Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × etoposide phosphate × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 4 Rhabdoid Tumor 3 Medulloblastoma 3 Lymphoma, B-Cell 3 Lymphoma 3 Leukemia 3 Ependymoma 3 Brain Neoplasms 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hodgkin Disease 2 Ganglioneuroblastoma 2 Small Cell Lung Carcinoma 1 Sarcoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Osteosarcoma 1 Nervous System Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Multiple Myeloma 1 Lymphoma, T-Cell 1

Interventions

X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Biopsy 4 ulixertinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Melphalan 2 Etoposide 2 trioctyl phosphine oxide 1 thymoglobulin 1 temsirolimus 1 tazemetostat 1 talazoparib 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 amino-acid, glucose, and electrolyte solution 1 Vincristine 1 Vemurafenib 1 Transplantation 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡